The NeuroDevNet Autism Spectrum Disorders Demonstration Project

Lonnie Zwaigenbaum, Stephen Scherer, Peter Szatmari, Eric Fombonne, Susan E. Bryson, Krista Hyde, Evdokia Anognostou, Jessica Brian, Alan Evans, Geoff Hall, David Nicholas, Wendy Roberts, Isabel Smith, Tracy Vaillancourt, Joanne Volden

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The NeuroDevNet Autism Spectrum Disorder Demonstration Project interfaces at many levels with the network's research themes and priorities. Our interdisciplinary team aims to improve understanding of genetic factors underlying vulnerability to autism spectrum disorders (ASDs) to develop better diagnostic strategies and, ultimately, to pinpoint molecular pathways relevant to developing biologically based treatments. Linking our existing longitudinal ASD cohorts with both genetics and neuroimaging studies will provide, for the first time, integrated data on how the genetic variation influences brain and behavioral development in ASD. Importantly, as our science progresses and we translate this information to the health care system, we will also educate policy makers, media, and business, so an informed society is prepared to capitalize on new genomic advances and effectively integrate these into health services for the broader community. We believe that this research has the potential to transform assessment and care for individuals with ASD.

Original languageEnglish (US)
Pages (from-to)40-48
Number of pages9
JournalSeminars in Pediatric Neurology
Volume18
Issue number1
DOIs
StatePublished - Mar 2011
Externally publishedYes

Fingerprint

Administrative Personnel
Research
Neuroimaging
Health Services
Autism Spectrum Disorder
Delivery of Health Care
Brain
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health

Cite this

Zwaigenbaum, L., Scherer, S., Szatmari, P., Fombonne, E., Bryson, S. E., Hyde, K., ... Volden, J. (2011). The NeuroDevNet Autism Spectrum Disorders Demonstration Project. Seminars in Pediatric Neurology, 18(1), 40-48. https://doi.org/10.1016/j.spen.2011.02.003

The NeuroDevNet Autism Spectrum Disorders Demonstration Project. / Zwaigenbaum, Lonnie; Scherer, Stephen; Szatmari, Peter; Fombonne, Eric; Bryson, Susan E.; Hyde, Krista; Anognostou, Evdokia; Brian, Jessica; Evans, Alan; Hall, Geoff; Nicholas, David; Roberts, Wendy; Smith, Isabel; Vaillancourt, Tracy; Volden, Joanne.

In: Seminars in Pediatric Neurology, Vol. 18, No. 1, 03.2011, p. 40-48.

Research output: Contribution to journalArticle

Zwaigenbaum, L, Scherer, S, Szatmari, P, Fombonne, E, Bryson, SE, Hyde, K, Anognostou, E, Brian, J, Evans, A, Hall, G, Nicholas, D, Roberts, W, Smith, I, Vaillancourt, T & Volden, J 2011, 'The NeuroDevNet Autism Spectrum Disorders Demonstration Project', Seminars in Pediatric Neurology, vol. 18, no. 1, pp. 40-48. https://doi.org/10.1016/j.spen.2011.02.003
Zwaigenbaum, Lonnie ; Scherer, Stephen ; Szatmari, Peter ; Fombonne, Eric ; Bryson, Susan E. ; Hyde, Krista ; Anognostou, Evdokia ; Brian, Jessica ; Evans, Alan ; Hall, Geoff ; Nicholas, David ; Roberts, Wendy ; Smith, Isabel ; Vaillancourt, Tracy ; Volden, Joanne. / The NeuroDevNet Autism Spectrum Disorders Demonstration Project. In: Seminars in Pediatric Neurology. 2011 ; Vol. 18, No. 1. pp. 40-48.
@article{603496b4a48b4d72bc200d5494b16e70,
title = "The NeuroDevNet Autism Spectrum Disorders Demonstration Project",
abstract = "The NeuroDevNet Autism Spectrum Disorder Demonstration Project interfaces at many levels with the network's research themes and priorities. Our interdisciplinary team aims to improve understanding of genetic factors underlying vulnerability to autism spectrum disorders (ASDs) to develop better diagnostic strategies and, ultimately, to pinpoint molecular pathways relevant to developing biologically based treatments. Linking our existing longitudinal ASD cohorts with both genetics and neuroimaging studies will provide, for the first time, integrated data on how the genetic variation influences brain and behavioral development in ASD. Importantly, as our science progresses and we translate this information to the health care system, we will also educate policy makers, media, and business, so an informed society is prepared to capitalize on new genomic advances and effectively integrate these into health services for the broader community. We believe that this research has the potential to transform assessment and care for individuals with ASD.",
author = "Lonnie Zwaigenbaum and Stephen Scherer and Peter Szatmari and Eric Fombonne and Bryson, {Susan E.} and Krista Hyde and Evdokia Anognostou and Jessica Brian and Alan Evans and Geoff Hall and David Nicholas and Wendy Roberts and Isabel Smith and Tracy Vaillancourt and Joanne Volden",
year = "2011",
month = "3",
doi = "10.1016/j.spen.2011.02.003",
language = "English (US)",
volume = "18",
pages = "40--48",
journal = "Seminars in Pediatric Neurology",
issn = "1071-9091",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - The NeuroDevNet Autism Spectrum Disorders Demonstration Project

AU - Zwaigenbaum, Lonnie

AU - Scherer, Stephen

AU - Szatmari, Peter

AU - Fombonne, Eric

AU - Bryson, Susan E.

AU - Hyde, Krista

AU - Anognostou, Evdokia

AU - Brian, Jessica

AU - Evans, Alan

AU - Hall, Geoff

AU - Nicholas, David

AU - Roberts, Wendy

AU - Smith, Isabel

AU - Vaillancourt, Tracy

AU - Volden, Joanne

PY - 2011/3

Y1 - 2011/3

N2 - The NeuroDevNet Autism Spectrum Disorder Demonstration Project interfaces at many levels with the network's research themes and priorities. Our interdisciplinary team aims to improve understanding of genetic factors underlying vulnerability to autism spectrum disorders (ASDs) to develop better diagnostic strategies and, ultimately, to pinpoint molecular pathways relevant to developing biologically based treatments. Linking our existing longitudinal ASD cohorts with both genetics and neuroimaging studies will provide, for the first time, integrated data on how the genetic variation influences brain and behavioral development in ASD. Importantly, as our science progresses and we translate this information to the health care system, we will also educate policy makers, media, and business, so an informed society is prepared to capitalize on new genomic advances and effectively integrate these into health services for the broader community. We believe that this research has the potential to transform assessment and care for individuals with ASD.

AB - The NeuroDevNet Autism Spectrum Disorder Demonstration Project interfaces at many levels with the network's research themes and priorities. Our interdisciplinary team aims to improve understanding of genetic factors underlying vulnerability to autism spectrum disorders (ASDs) to develop better diagnostic strategies and, ultimately, to pinpoint molecular pathways relevant to developing biologically based treatments. Linking our existing longitudinal ASD cohorts with both genetics and neuroimaging studies will provide, for the first time, integrated data on how the genetic variation influences brain and behavioral development in ASD. Importantly, as our science progresses and we translate this information to the health care system, we will also educate policy makers, media, and business, so an informed society is prepared to capitalize on new genomic advances and effectively integrate these into health services for the broader community. We believe that this research has the potential to transform assessment and care for individuals with ASD.

UR - http://www.scopus.com/inward/record.url?scp=79955978066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955978066&partnerID=8YFLogxK

U2 - 10.1016/j.spen.2011.02.003

DO - 10.1016/j.spen.2011.02.003

M3 - Article

C2 - 21575840

AN - SCOPUS:79955978066

VL - 18

SP - 40

EP - 48

JO - Seminars in Pediatric Neurology

JF - Seminars in Pediatric Neurology

SN - 1071-9091

IS - 1

ER -